What is the current stock price of Kestra Medical Technologies, Ltd. (KMTS)?

As of the latest market data, Kestra Medical Technologies, Ltd. (KMTS) is trading at $17.87. The stock has seen a loss of -7.17% today.

Does Kestra Medical Technologies, Ltd. (KMTS) pay a dividend?

Based on current data, Kestra Medical Technologies, Ltd. does not have a confirmed active dividend policy.

What is the market cap of Kestra Medical Technologies, Ltd.?

The current market capitalization of Kestra Medical Technologies, Ltd. (KMTS) is approximately unavailable.

KMTS

Kestra Medical Technologies, Ltd.·Healthcare

17.87

7.169%(−1.38)

Market Closed

17.91

0.224%(+0.04)

After Hours

Last Updated: — ET

52W L: $13.2552W H: $30.00

KMTS NEWS

globenewswire.com

2d ago

Kestra Medical Technologies Named a 2026 USA TODAY Top Workplaces Award Winner

KIRKLAND, Wash., April 09, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd.

fool.com

Apr 3

The Kestra Director Who Built and Sold a Device Company Keeps Buying Stock

Director Raymond W. Cohen acquired 10,000 shares for a transaction value of approximately $200,000 on March 26, 2026.

globenewswire.com

Mar 25

Kestra Medical Technologies Named Finalist for 2026 GeekWire “Deal of the Year”

KIRKLAND, Wash., March 25, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a leading wearable medical device and digital healthcare company, today announced it has been named a finalist in the “Deal of the Year” category for the 2026 GeekWire Awards. Now in its 15th year, the annual awards recognize companies and leaders shaping the Pacific Northwest technology ecosystem, where Kestra continues to expand its presence.

defenseworld.net

Mar 22

Kestra Medical Technologies (NASDAQ:KMTS) Insider Sells $304,050.00 in Stock

Kestra Medical Technologies, Ltd. (NASDAQ: KMTS - Get Free Report) insider Brian Daniel Webster sold 15,000 shares of the company's stock in a transaction that occurred on Tuesday, March 17th. The stock was sold at an average price of $20.27, for a total transaction of $304,050.00. Following the sale, the insider directly owned 364,786 shares of

seekingalpha.com

Mar 17

Kestra Medical Technologies, Ltd. (KMTS) Q3 2026 Earnings Call Transcript

globenewswire.com

Mar 17

Kestra Medical Technologies Reports Third Quarter Fiscal 2026 Financial Results

KIRKLAND, Wash., March 17, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a leading wearable medical device and digital healthcare company, today reported financial results for the third quarter fiscal 2026, which ended January 31, 2026.

Company Profile

Kestra Medical Technologies, Ltd. operates as a wearable medical device and digital healthcare company. It focuses on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. The company develops and commercializes Cardiac Recovery System platform, a system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. Its Cardiac Recovery System platform is the ASSURE WCD, a wearable cardioverter defibrillator (WCD) used to protect patients at an elevated risk of sudden cardiac arrest (SCA). The company's Cardiac Recovery System platform also includes a suite of integrated digital solutions and services that enable enhanced patient and provider engagement and oversight with the objective of improving patient outcomes. The company was founded in 2014 and is based in Kirkland, Washington.

Sector

Healthcare

Industry

Medical - Instruments & Supplies

Employees

300

IPO Date

2025-03-06

Beta

1.09

Websitekestramedical.com↗